Literature DB >> 11249829

Profile of moxifloxacin drug interactions.

H Stass1, D Kubitza.   

Abstract

We report a brief description of the interaction profile of moxifloxacin. After oral administration, the absorption of moxifloxacin was unaffected by ranitidine or by food consumption. Drugs containing multivalent cations (e.g., Mg(++), Al(+++), and Fe(++), but not Ca(++)) impaired absorption. No clinically relevant effect of moxifloxacin was seen on the pharmacokinetics of digoxin under combination steady state conditions. Also, moxifloxacin did not affect the pharmacokinetics of theophylline or vice versa. This result, plus further data proving lack of interaction with glyburide, warfarin, and oral contraceptives, confirms the absence of metabolic interactions involving the cytochrome P-450 system, as previously reported. Concomitant administration of probenecid did not affect the elimination of moxifloxacin. Moxifloxacin thus has a unique drug interaction profile that is advantageous for its safe use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249829     DOI: 10.1086/319376

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.

Authors:  Xian Chen; Jessica D Cass; Jenifer A Bradley; Corinn M Dahm; Zhuoqian Sun; Edmund Kadyszewski; Michael J Engwall; Jun Zhou
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.

Authors:  Ayman M Noreddin; Virginia Haynes
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 3.  Moxifloxacin in uncomplicated skin and skin structure infections.

Authors:  Richard B R Muijsers; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.

Authors:  Jorg Taubel; Georg Ferber; Ulrike Lorch; Velislav Batchvarov; Irina Savelieva; A John Camm
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 5.  Moxifloxacin: a review of its use in the management of bacterial infections.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.

Authors:  Fatih Yildiz; Behice Kurtaran; Murat Cayli; Aslihan Candevir; Zehra Sümbül
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

Review 7.  Gender analysis of moxifloxacin clinical trials.

Authors:  Elisa Chilet-Rosell; Ma Teresa Ruiz-Cantero; Ma Angeles Pardo
Journal:  J Womens Health (Larchmt)       Date:  2013-11-01       Impact factor: 2.681

8.  Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials.

Authors:  Vincent T Andriole; Daniel C Haverstock; Shurjeel H Choudhri
Journal:  Drug Saf       Date:  2005       Impact factor: 5.228

9.  Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.

Authors:  Lawrence J Lesko; Elliot Offman; Christine Taylor Brew; Dahlia Garza; Wade Benton; Martha R Mayo; Alain Romero; Charles Du Mond; Matthew R Weir
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-02-13       Impact factor: 2.457

10.  Lithium Intoxication: A Possible Interaction with Moxifloxacin.

Authors:  Selvi Kayipmaz; Ali Ercan Altınöz; Nadide Elmas Gülcü Ok
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.